#hepatocellular carcinoma

Liver cancer is now less likely to be caused by hepatitis B or C, but more likely to be caused by fatty liver disease or alcohol.

More than a third of hepatocellular carcinoma cases among Medicare recipients were due to fatty liver disease.

Cases of the most common type of liver cancer, hepatocellular carcinoma, are on the rise.

Over the next two decades, obesity-linked NASH will lead to more deaths and high cost in the United States.

Less than 10% of people with cirrhosis were regularly monitored for liver cancer.

From 1995 to 2016, hepatocellular carcinoma incidence in rural populations climbed by 218%.

From 1992 to 2018, liver cancer cases related to hepatitis C fell in Japan.

Use of cholesterol-lowering medications was also associated with reduced mortality from liver cancer and other causes.

But a simple improvement in dietary intake reversed fatty liver disease and staved off cancer.

Disruptions in access to treatment and harm reduction services could set back effort to eliminate hep C in the U.S.

Coffee drinkers appear to have a 49% lower risk of dying of chronic liver disease.

Mice that performed modest exercise were less likely to show signs of inflammation, cell aging and liver cancer.

Compared to other racial and ethnic groups, Blacks are also less likely to be diagnosed early.

Areas with lower population density have not seen the same slowdown as urban areas.

Readily available clinical parameters can identify those at greatest risk for hepatocellular carcinoma.

Many people with fatty liver disease have obesity, diabetes and other metabolic conditions.